date:Dec 04, 2018
that Wanglaoji's annual sales in the first half of 2018 still maintained double-digit growth. From January to September this year, Guangzhou Pharmaceutical Group realized sales revenue of 87.203 billion yuan, an increase of 11.82% over the same period last year, and realized total profits of 4.044 billion yuan, an increase of 50.47% over the same period last year.
Sourceļ¼www.xxsb.com